242 related articles for article (PubMed ID: 15761199)
1. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon.
Klein G; Schaefer A; Hilfiker-Kleiner D; Oppermann D; Shukla P; Quint A; Podewski E; Hilfiker A; Schröder F; Leitges M; Drexler H
Circ Res; 2005 Apr; 96(7):748-55. PubMed ID: 15761199
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor 5 regulates cardiac repair after myocardial infarction.
Zaidi SH; Huang Q; Momen A; Riazi A; Husain M
J Am Coll Cardiol; 2010 Jan; 55(2):135-43. PubMed ID: 20117381
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
4. Loss of TRADD attenuates pressure overload-induced cardiac hypertrophy through regulating TAK1/P38 MAPK signalling in mice.
Wu L; Cao Z; Ji L; Mei L; Jin Q; Zeng J; Lin J; Chu M; Li L; Yang X
Biochem Biophys Res Commun; 2017 Feb; 483(2):810-815. PubMed ID: 28013046
[TBL] [Abstract][Full Text] [Related]
5. Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-kappa B, p38 and JNK MAPK pathway.
Ghosh J; Das J; Manna P; Sil PC
Toxicol Appl Pharmacol; 2009 Oct; 240(1):73-87. PubMed ID: 19616567
[TBL] [Abstract][Full Text] [Related]
6. The I{kappa}B kinase {beta}/nuclear factor {kappa}B signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression.
Hikoso S; Yamaguchi O; Nakano Y; Takeda T; Omiya S; Mizote I; Taneike M; Oka T; Tamai T; Oyabu J; Uno Y; Matsumura Y; Nishida K; Suzuki K; Kogo M; Hori M; Otsu K
Circ Res; 2009 Jul; 105(1):70-9. PubMed ID: 19478205
[TBL] [Abstract][Full Text] [Related]
7. ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy.
Adiarto S; Heiden S; Vignon-Zellweger N; Nakayama K; Yagi K; Yanagisawa M; Emoto N
Life Sci; 2012 Oct; 91(13-14):651-7. PubMed ID: 22365964
[TBL] [Abstract][Full Text] [Related]
8. AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice.
Zhang P; Hu X; Xu X; Fassett J; Zhu G; Viollet B; Xu W; Wiczer B; Bernlohr DA; Bache RJ; Chen Y
Hypertension; 2008 Nov; 52(5):918-24. PubMed ID: 18838626
[TBL] [Abstract][Full Text] [Related]
9. HSP75 protects against cardiac hypertrophy and fibrosis.
Zhang Y; Jiang DS; Yan L; Cheng KJ; Bian ZY; Lin GS
J Cell Biochem; 2011 Jul; 112(7):1787-94. PubMed ID: 21381076
[TBL] [Abstract][Full Text] [Related]
10. Blockade of calcineurin reverses cardiac hypertrophy and induces the down-regulation of JNK mRNA expression in renovascular hypertensive rats.
Hongzhuan Sheng ; Jianhua Zhu ; Xiaohui Wu ; Jinan Zhang
J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):139-45. PubMed ID: 18957384
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
[TBL] [Abstract][Full Text] [Related]
12. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotection of exogenous erythropoietin in mice with ligature-induced aortic stenosis: effects on maladaptive cardiac hypertrophy.
Zheng L; Xu J; Qiu W; Liu X; Zhao CM; Chen D; Chen Y
J Physiol Pharmacol; 2010 Feb; 61(1):13-20. PubMed ID: 20228410
[TBL] [Abstract][Full Text] [Related]
14. MK5 haplodeficiency attenuates hypertrophy and preserves diastolic function during remodeling induced by chronic pressure overload in the mouse heart.
Nawaito SA; Dingar D; Sahadevan P; Hussein B; Sahmi F; Shi Y; Gillis MA; Gaestel M; Tardif JC; Allen BG
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H46-H58. PubMed ID: 28432058
[TBL] [Abstract][Full Text] [Related]
15. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
[TBL] [Abstract][Full Text] [Related]
16. Pressure overload-induced alterations in fibrillar collagen content and myocardial diastolic function: role of secreted protein acidic and rich in cysteine (SPARC) in post-synthetic procollagen processing.
Bradshaw AD; Baicu CF; Rentz TJ; Van Laer AO; Boggs J; Lacy JM; Zile MR
Circulation; 2009 Jan; 119(2):269-80. PubMed ID: 19118257
[TBL] [Abstract][Full Text] [Related]
17. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.
Yu L; Ruifrok WP; Meissner M; Bos EM; van Goor H; Sanjabi B; van der Harst P; Pitt B; Goldstein IJ; Koerts JA; van Veldhuisen DJ; Bank RA; van Gilst WH; Silljé HH; de Boer RA
Circ Heart Fail; 2013 Jan; 6(1):107-17. PubMed ID: 23230309
[TBL] [Abstract][Full Text] [Related]
18. CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload.
Fontes MS; Kessler EL; van Stuijvenberg L; Brans MA; Falke LL; Kok B; Leask A; van Rijen HV; Vos MA; Goldschmeding R; van Veen TA
J Mol Cell Cardiol; 2015 Nov; 88():82-90. PubMed ID: 26410398
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin is required for cardiac MEF2 activation during pressure overload induced hypertrophy.
Dadson K; Turdi S; Hashemi S; Zhao J; Polidovitch N; Beca S; Backx PH; McDermott JC; Sweeney G
J Mol Cell Cardiol; 2015 Sep; 86():102-9. PubMed ID: 26196305
[TBL] [Abstract][Full Text] [Related]
20. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
Fan D; Takawale A; Basu R; Patel V; Lee J; Kandalam V; Wang X; Oudit GY; Kassiri Z
Cardiovasc Res; 2014 Jul; 103(2):268-80. PubMed ID: 24692173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
